Connection
Eric Wu to Antidepressive Agents, Second-Generation
This is a "connection" page, showing publications Eric Wu has written about Antidepressive Agents, Second-Generation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.469 |
|
|
|
-
Wu EQ, Ben-Hamadi R, Yu AP, Tang J, Haim Erder M, Bose A. Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons. J Med Econ. 2010; 13(2):314-23.
Score: 0.305
-
Yu AP, Ben-Hamadi R, Wu EQ, Kaltenboeck A, Bergman R, Xie J, Blum S, Erder MH. Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs. J Med Econ. 2011; 14(4):508-15.
Score: 0.084
-
Yu AP, Xie J, Bensimon A, Parikh K, Wu EQ, Ben-Hamadi R, Blum S, Haim Erder M. Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study. J Med Econ. 2010; 13(4):599-609.
Score: 0.080